Does aliskiren-based treatment reduce central aortic blood pressure comparably to ramipril-based treatment in elderly patients with systolic hypertension?
Aliskiren may offer effective control of central blood pressure comparable to ramipril in elderly patients with systolic hypertension.
Aliskiren-based therapy provides comparable reductions in CASP to ramipril-based therapy. Although the results did not reach statistical significance, these findings, when coupled with those of the main study, suggest that aliskiren may offer effective control of central BP in elderly patients with systolic hypertension and may be a good alternative to ramipril.
Baschiera et al. (Sun,) studied this question.